Stockreport

Wolf Popper LLP Investigates the Proposed Acquisition of Keryx Biopharmaceuticals, Inc. by Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF NEW YORK, July 23, 2018 /PRNewswire/ -- Wolf Popper LLP is investigating claims on behalf of investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), concerning the p [Read more]